# Avicenna Biosciences

> Avicenna Biosciences, Inc. is a Durham, North Carolina drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate optimization process for small molecule drug development. Founded in 2020, backed by DCVC Bio. Avicenna publishes no public API, developer portal, or machine-readable interface.

## Company

- [Avicenna Biosciences](https://www.avicenna-bio.com/): Corporate website
- [Approach](https://www.avicenna-bio.com/approach): The machine learning-enhanced medicinal chemistry platform
- [Team](https://www.avicenna-bio.com/team): Leadership and scientific team
- [News](https://www.avicenna-bio.com/news): Company announcements and press releases
- [LinkedIn](https://www.linkedin.com/company/avicenna-biosciences): Company profile
- [DCVC portfolio profile](https://www.dcvc.com/companies/avicenna-biosciences/): Investor profile

## APIs

No public APIs. Avicenna Biosciences is catalogued in the API Evangelist network as an AI-for-drug-discovery company profile, not as an API provider.

## Artifacts

- [Domain security](security/avicenna-biosciences-domain-security.yml): Probed TLS/HSTS/DNSSEC/CAA/SPF/DMARC posture
- [Well-known probe](well-known/avicenna-biosciences-well-known.yml): /.well-known/ discovery surface probe results (all 404)

## Notes

- Sector: biotechnology, small molecule drug discovery, computational/ML-driven medicinal chemistry
- Therapeutic focus: neurodegenerative disease, including Rho kinase inhibitors for Parkinson's disease and ALS
- Generated by the API Evangelist enrichment pipeline on 2026-07-20 from apis.yml and repo artifacts.